Significant response to apatinib monotherapy in heavily pretreated advanced HER2-positive breast cancer: a case report and literature review

Although HER2-targeted therapy has been shown to prolong the survival of patients with HER2-positive breast cancer, most patients eventually progress due to drug resistance. Novel treatment options are urgently needed to overcome resistance to HER2-targeted therapy. The VEGF/VEGFR (Vascular endothel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Biol Ther
Autors principals: Danni, Li, Lingyun, Zhang, Jian, Wang, Hongfei, Yan, Lu, Xu, Peng, Yang, Xiujuan, Qu, Yunpeng, Liu, Yuee, Teng
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Bedside-to-Bench Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515454/
https://ncbi.nlm.nih.gov/pubmed/32233990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1743159
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars